Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association's 2023 Annual MeetingBusiness Wire • 05/20/23
Teva Pharmaceutical announces new growth strategy built on biosimilars, innovationMarket Watch • 05/18/23
AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now Available in the U.S.Business Wire • 05/15/23
Teva Pharmaceutical Industries Limited (TEVA) Q1 2023 Earnings Call TranscriptSeeking Alpha • 05/10/23
Compared to Estimates, Teva Pharmaceutical Industries Ltd. (TEVA) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 05/10/23
Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat SalesInvestors Business Daily • 05/10/23
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP OutlookBusiness Wire • 05/10/23
Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of ScheduleBusiness Wire • 05/09/23
MedinCell: mdc-TJK's (Teva's codename: TEV-44749) Phase 1 study pharmacokinetics to be presented for the first time by Teva at SIRS 2023 (May 11-15, 2023, Toronto, Canada)Business Wire • 05/04/23
U.S. Mental Health Access Program Expands Medicine Donation to Seven New StatesBusiness Wire • 05/03/23
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in AdultsBusiness Wire • 04/29/23
Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023Business Wire • 04/14/23
Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual MeetingBusiness Wire • 04/11/23
The Byzantine Adderall Shortage Puts Teva And Others In The Hot SeatInvestors Business Daily • 04/05/23